RETRACTED ARTICLE: Therapeutic Effects of Panax notoginseng saponins in Rheumatoid Arthritis: Network Pharmacology and Experimental Validation
Open Access
- 1 June 2022
- journal article
- retracted article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (6) , 14438-14449
Abstract
Panax notoginseng saponins (PNS) have been reported to have good anti-inflammatory effects. However, the anti-inflammatory effect mechanism in rheumatoid arthritis (RA) remains unknown. The focus of this research was to investigate the molecular mechanism of PNS in the treatment of RA. The primary active components of PNS were tested utilizing the Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and Analysis Platform based on oral bioavailability and drug-likeness. The target databases for knee osteoarthritis were created using GeneCards and Online Mendelian Inheritance in Man (OMIM). The visual interactive network structure ‘active component – action target – illness’ was created using Cytoscape software. A protein interaction network was built, and associated protein interactions were analyzed using the STRING database. The key targets were analyzed using Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway and Gene Ontology (GO) biological process enrichment analyses. The effects of PNS on cell growth were studied in human umbilical vein endothelial cells (HUVECs) treated with various doses of PNS, and the optimum concentration of PNS was identified. PNS was studied for its implication on angiogenesis and migration. The active components of PNS had 114 common targets, including cell metabolism and apoptosis, according to the network analysis. The therapeutic effects of the PNS components were suggested to be mediated through apoptotic and cytokine signaling pathways. In vitro, PNS therapy boosted HUVEC proliferation. Wound healing, Boyden chamber and tube formation tests suggested that PNS may increase HUVEC activity and capillary-like tube branching. This study clarified that for the treatment of RA, PNS has multisystem, multicomponent, and multitargeted properties. GRAPHICAL ABSTRACTKeywords
Funding Information
- National Natural Science Foundation of China (81772362)
- Natural Science Foundation of Heilongjiang Province (JQ2020H003)
- Natural Science Foundation of Heilongjiang Province (JQ2020H003)
This publication has 46 references indexed in Scilit:
- Phytochemical constituents as future antidepressants: a comprehensive reviewReviews in the Neurosciences, 2015
- Notoginsenoside R1 Attenuates Experimental Inflammatory Bowel Disease via Pregnane X Receptor ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2015
- Molecular Pathways: Molecular Basis for Sensitivity and Resistance to JAK Kinase InhibitorsClinical Cancer Research, 2014
- Involvement of histamine 4 receptor in the pathogenesis and progression of rheumatoid arthritisInternational Immunology, 2014
- A travel guide to Cytoscape pluginsNature Methods, 2012
- Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathwaysBiochemical Pharmacology, 2012
- Jakinibs: a new class of kinase inhibitors in cancer and autoimmune diseaseCurrent Opinion in Pharmacology, 2012
- Janus kinases in immune cell signalingImmunological Reviews, 2009
- New therapies for treatment of rheumatoid arthritisThe Lancet, 2007
- Network biology: understanding the cell's functional organizationNature Reviews Genetics, 2004